Search

everythinglearnresearchcommunity

for

Search:↓

Research 10 of 131

1. Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata Drug Design Development and Therapy · 2022 · 49 citations
2. Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study Journal of The American Academy of Dermatology · 2021 · 66 citations
3. How Long to Treat to Achieve Desired Treatment Outcomes with Baricitinib 4 mg in Severe Alopecia Areata: Evidence-based Approach Dermatology and Therapy · 2026
4. Comparative efficacy and safety of JAK inhibitors in the treatment of moderate-to-severe alopecia areata: a systematic review and network meta-analysis Frontiers in pharmacology · 2024
5. Comparative Efficacy and Safety of Janus Kinase Inhibitors Used in Alopecia Areata: A Systematic Review and Meta-analysis Acta dermato-venereologica · 2023 · 10 citations
6. Effectiveness and safety of baricitinib in severe alopecia areata: 48-week results Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) · 2026
7. Effectiveness and safety of baricitinib in severe alopecia areata: 48‐week results Journal of the European Academy of Dermatology and Venereology · 2025
8. Journal of Population Therapeutics and Clinical Pharmacology 2025
9. Real‐life effectiveness and safety of baricitinib in patients with severe alopecia areata: A 24‐week Italian study Journal of the European Academy of Dermatology and Venereology · 2024
10. COMPARISON OF EFFICACY OF BARICITINIB VERSUS METHOTREXATE THERAPY IN THE TREATMENT OF SEVERE ALOPECIA AREATA 2025 · 1 citations

Community

— no results